The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

StocksUpdated×3•Originally published 29 April 2026•Updated 30 April 2026•

1 min read

Q1 Earnings Update: Kymera and ProPetro Beat Estimates While SunCoke and OneWater Miss

Key Facts

1Agios Pharmaceuticals reported a quarterly loss of $1.69 per share, beating the Zacks Consensus Estimate of a loss of $1.81.

2Lemonade reported a quarterly loss of $0.47 per share, surpassing the Zacks Consensus Estimate of a loss of $0.58.

The first-quarter earnings season continues to show mixed results, highlighted by a significant beat from Agios Pharmaceuticals, which saw its stock price jump 13% after exceeding earnings and sales estimates. Agios reported a 138% surge in revenue, driven by momentum from new drugs and pipeline advancements. Meanwhile, Kymera Therapeutics reported a Q1 loss of $0.71 per share, beating estimates, and ProPetro Holding outperformed with a loss of only $0.03 per share. However, the trend was dampened by SunCoke Energy, which posted a surprise $0.05 loss per share, and OneWater Marine, which significantly missed targets with a $0.34 loss. These updated results highlight the ongoing operational volatility across the biotech, energy, and consumer discretionary sectors.

about 1 month ago

Version History

Version 3about 1 month ago

What changed: Added Agios Pharmaceuticals' strong Q1 performance, including its earnings beat, 13% stock surge, and 138% revenue growth.

Version 2about 1 month ago

What changed: The story was updated to include disappointing results from SunCoke, OneWater, and Cartesian, alongside positive beats from Kymera and ProPetro.

Version 1about 1 month ago

What changed: The story was updated to include Q1 earnings beats from Ionis Pharmaceuticals and Smith Douglas Homes Corp, both of which reported narrower-than-expected losses.